Skip to main content
Clinical Cardiology logoLink to Clinical Cardiology
. 2014 Jun 9;37(10):645–649. doi: 10.1002/clc.22301

Cardiac Platypnea‐Orthodeoxia Syndrome: An Often Unrecognized Malady

Joseph T Knapper 1,, Jason Schultz 2, Gladwin Das 2, Laurence S Sperling 1
PMCID: PMC6649356  PMID: 24912004

Abstract

Platypnea‐orthodeoxia syndrome (POS) is a rare but clinically important form of dyspnea. The syndrome is characterized by dyspnea and arterial oxygen desaturation that occurs in the upright position and improves with recumbency. In cardiac POS, an atrial septal defect or patent foramen ovale allows communication between the right‐ and left‐sided circulations. A second defect, such as a dilated aorta, prominent eustachian valve, or pneumonectomy, then contributes to right‐to‐left shunting through the interatrial connection. Diagnosis is made through pulse oximetry to confirm orthodeoxia and through transesophageal echocardiography with bubble study to visualize the shunt. Although data are limited for this rare syndrome, percutaneous closure has thus far proven safe and effective.

Introduction

Dyspnea is a frequently encountered symptom in medicine. Of the top 6 reasons for patients to be hospitalized through the emergency department, dyspnea is either the primary symptom or an associated symptom in all 6.1 Dyspnea is also a complaint of nearly 4% of patients seeking treatment in the ambulatory care setting, and population samples have determined the prevalence of dyspnea to be between 17% and 38%.2

Unfortunately, many of the most common causes of dyspnea, such as chronic obstructive pulmonary disease and congestive heart failure, are not fully reversible. Treatments for these conditions are typically targeted toward slowing disease progression and controlling symptoms, rather than curing the underlying disease process. In this context, clinicians must be particularly aware of dyspnea syndromes that are fully reversible. Platypnea‐orthodeoxia syndrome (POS) represents 1 of these entities. As detailed in this review, POS is frequently debilitating to the patients who suffer from it. However, when POS is identified, a safe and relatively simple procedure can lead to dramatic symptom improvement.

Case Report

A 46‐year‐old male with a past medical history significant for anaplastic large cell lymphoma was evaluated for dyspnea. A right pneumonectomy had been performed 2 months prior to the current admission, which was initially tolerated well.

He was seen at a community hospital 1 month ago complaining of increasing shortness of breath, which he attributed to noxious fumes from his furnace. The evaluation was notable for an initial oxygen saturation of 65% on room air, a negative ventilation‐perfusion scan, negative lower extremity Doppler ultrasound, and a negative pulmonary angiogram. A transthoracic echocardiogram demonstrated mild right ventricular dilatation and mild left ventricular dysfunction, and a transesophageal echocardiogram showed a large patent foramen ovale (PFO) with significant right‐to‐left shunting. Cardiac catheterization was performed and demonstrated normal coronary arteries and normal left ventricular function. Right heart pressures and cardiac output were normal. The patient was placed on 4 L of oxygen by nasal cannula. His dyspnea improved and he was discharged.

The patient's dyspnea returned within the month, and he was readmitted for further evaluation. The transesophageal echocardiogram was repeated, and importantly, the study was performed in both the upright and supine positions. Flow across the PFO was significantly higher in the upright than the supine position, consistent with the lower oxygen saturation seen in the upright position. The patient's PFO was closed percutaneously using a 22‐mm septal occluder device placed in the interatrial septum. A postprocedure echocardiographic bubble study was negative for shunting.

The patient's dyspnea immediately improved. At the time of discharge, oxygen saturations were in the upper 90s on room air, and he was able to maintain those saturations with moderate exercise.

Definition and Clinical Presentation

POS is a rare but clinically important form of dyspnea. The syndrome is characterized by dyspnea that occurs in the upright position and is relieved by recumbency (platypnea).3 A significant drop in arterial oxygen saturation is noted when moving from the supine to the upright position (orthodeoxia), although there is often a mild hypoxemia present even while supine.4 Due to the pathophysiology of orthodeoxia (see Mechanisms of Cardiac POS below), paradoxical embolism is a frequent coexisting condition.5

Since its original description by Burchell and Wood in 1949, there have been <150 case reports in the literature.6 Although the recognition of POS does seem to be increasing, with over 80 case reports in the last decade alone, it likely remains underdiagnosed.7 Cardiac etiologies are most frequently associated with platypnea‐orthodeoxia, and will be the focus of this review.

Mechanisms of Cardiac POS

Though a unifying mechanism has yet to be determined, position‐dependent right‐to‐left shunting appears to underlie POS. This shunting requires both an anatomic and functional defect.8 Anatomic defects allow communication between the right‐ and left‐sided circulation. In cardiac POS, the anatomic defect is either a PFO (more common) or an atrial septal defect (ASD). Although interatrial right‐to‐left shunting is expected in the setting of elevated pulmonary pressures, these pressures are usually normal in POS.9 For this reason, a second, functional, defect is required to shunt deoxygenated blood into the higher pressure systemic circulation (Table 1). These functional defects can generally be classified into 2 groups: (1) those that preferentially direct blood flow through the interatrial communication and (2) those that cause a transient increase in right atrial pressure resulting in a transient right‐left atrial gradient.10 Even though it is possible for several functional defects to be present, the majority of patients reported in the literature have only 1 anatomic and 1 functional defect.

Table 1.

Functional Defects Associated With Cardiac Platypnea‐Orthodeoxia Syndrome

Group A: Direction of Blood Flow Through Interatrial Communication Group B: Transient Reversal of Left‐to‐Right Pressure Gradient
Absent superior vena cava Chronic obstructive pulmonary disease
Aortic valve replacement Constrictive pericarditis
Ascending aorta repair Pericardial adipose deposition compressing right ventricle inflow tract
Ascending aortic aneurysm Pericardial effusion
Atrial septal aneurysm Pneumonectomy
Atrial switch procedure Pulmonary embolism
Cardiac cyst/mass Pulmonary hypertension
Coronary sinus dilatation Right ventricular ischemia
Ebstein's anomaly
Eosinophilic endomyocardial disease
Fontan procedure
Hepatic cyst distorting right atrium
Lipomatous hypertrophy of the interatrial septum
Paraesophageal hernia repair
Partial anomalous venous return
Persistent left superior vena cava
Prominent eustachian valve
Tortuous ascending aorta
Transposition of the great vessels
Tricuspid regurgitation
Tricuspid stenosis
Unroofed coronary sinus

The first group of functional defects are those that preferentially direct blood flow through the interatrial communication. The normal pattern of venous blood return from the superior vena cava is downward in the anterior half of the right atrium, whereas blood from the inferior vena cava flows upward in the posterior half.11 In most patients with ASDs or PFOs, neither of these streams is aimed directly at the interatrial communication. However, when a second, functional defect distorts the usual cardiac anatomy, a change in position can allow deoxygenated blood (typically from the inferior vena cava) to flow directly across the ASD or PFO into the left atrium.8 These functional defects can either reposition the atrial septum (aortic dilation/aneurysm, atrial septal aneurysm, intracardiac lipoma, cardiac surgeries) or redirect the blood flow from the inferior vena cava (prominent eustachian valve). Occasionally, a tricuspid regurgitant jet can also be projected directly through the interatrial communication.12

The other group of functional defects act through transient reversal of the left‐to‐right pressure gradient.11 These conditions elevate right atrial pressures to the point that the left‐to‐right pressure gradient reverses for certain parts of the cardiac cycle, particularly when the patient is in the upright position. These conditions either increase pulmonary vascular resistance (pneumonectomy, pulmonary embolism, chronic obstructive pulmonary disease, pulmonary hypertension), require high right‐sided filling pressures to maintain cardiac output (constrictive pericarditis, pericardial effusion), or lead to decreased right‐sided compliance (right ventricular ischemia).

Mimics of Cardiac POS

Patients can present with symptoms of platypnea and orthodeoxia without a specific underlying cardiac etiology. Nonetheless, similar anatomic and functional defects must be present. Instead of an ASD or PFO permitting right‐to‐left communication, the anatomic defect is typically a pulmonary arteriovenous malformation, or severe ventilation‐perfusion mismatching. Functional defects (Table 2) increase blood flow through the pulmonary arteriovenous malformations or increase the severity of ventilation‐perfusion mismatching. A particularly interesting association is seen with chronic liver disease, whereby worsening liver disease has been shown to correlate with worsening oxygen desaturation on standing,13 most likely related to the development of pulmonary arteriovenous malformations through the hepatopulmonary syndrome.

Table 2.

Noncardiac Conditions Associated With Platypnea‐Orthodeoxia Syndrome

Pulmonary Abdominal Other
Acute respiratory distress syndrome Bowel obstruction or ileus Chest wall trauma
Chronic obstructive pulmonary disease Hepatopulmonary syndrome Diabetic autonomic neuropathy
Cryptogenic fibrosing alveolitis Alcoholic liver cirrhosis Kyphoscoliosis
Fat embolism Autoimmune hepatitis Organophosphate poisoning
Hemidiaphragmatic dysfunction Hepatitis A Paraesophageal hernia repair
Pleural effusion Noncirrhotic portal hypertension Parkinson's disease
Pneumocystis and cytomegalovirus pneumonia Schistosomiasis Propafenone overdose
Pneumonectomy Vertebral fractures
Pulmonary arteriovenous malformations
Pulmonary embolism
Radiation‐induced bronchial stenosis
Traumatic bronchial rupture
Ventilation/perfusion mismatching

Diagnosis

POS should be suspected in any patient with dyspnea that worsens in the upright position and improves with recumbency. An insufficient rise in arterial oxygen saturation despite the patient breathing 100% oxygen also increases suspicion.5 The confirmatory finding for POS is a position‐dependent drop in arterial oxygen saturation, with or without the use of a tilt table.

Once the diagnosis of POS has been established, an attempt should be made to determine the underlying etiology. Intracardiac shunting has been the most frequently implicated finding in reports of POS. Transesophageal echocardiography is the preferred diagnostic modality, providing good visualization of any defects or aneurysms that may be present in the atrial septum.4 An intravenous agitated bubble study should be done to assess for the presence of right‐to‐left shunting.4 The test is considered positive for shunt if any bubbles appear within the left atrium, and suggests an intracardiac shunt if those bubbles appear within 3 cardiac cycles.14 Intravenous fluid replacement or performance of the Valsalva maneuver can significantly increase the sensitivity of the bubble study, and should be considered if no shunt is detected despite a strong clinical suspicion.5, 15 Other modalities for assessing intracardiac defects include right‐heart catheterization, ventilation‐perfusion scan demonstrating early extrapulmonary uptake,16 and transcranial Doppler4; however, these tests should typically be employed only in the setting of an inconclusive echocardiographic study. Cardiac magnetic resonance imaging can also be used to search for distortions in normal cardiac anatomy, which may explain the right‐to‐left shunting.17 If no intracardiac lesion is identified, pulmonary, abdominal, or other conditions known to cause POS should be investigated.

Treatment

Definitive treatment for POS secondary to intracardiac shunting involves closure of the interatrial defect. The decision to pursue definitive treatment must be made with careful consideration of not only the severity of the patient's symptoms, but also the patient's underlying medical conditions and ability to tolerate an invasive procedure. Recently, percutaneous closure has supplanted cardiac surgery for treatment of ASDs and PFOs, given its decreased morbidity, mortality, and expense.3 Percutaneous intervention has also been successful in the specific setting of ASD or PFO closure in patients with POS. Table 3 shows results from all available case series.18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29

Table 3.

Reported Case Series Regarding Treatment of Cardiac Platypnea‐Orthodeoxia Syndrome

Author Year No. of Patients Treatment Closure Success or Symptom Resolution (%) Absolute Increase in SpO2 Major In‐Hospital Complications Follow‐up Period Follow‐Up Results
Takaya 2014 3 Perc 100 10 None
Zavalloni 2013 6 Perc 100 17 1 death (unrelated septic shock) Mean 3 months 1 cardioembolic TIA, 3 repeat interventions
Blanche 2013 5 Perc 100 10 None Median 6 months No late complications or repeat procedures
Sanikommu 2009 7 Perc 100 None
Toffart 2008 8 6 (Perc)/2 (Surg) 83 (Perc)/100 (Surg) 1 unrelated death in percutaneous group Mean 2.3 years 2 unrelated deaths, 1 repeat intervention
Guerin 2005 78 Perc 97 10 2 deaths (unrelated to procedure) Mean 1.3 years 7 late deaths unrelated to procedure
Delgado 2004 18 Perc 100 13 None Mean 2.9 years 2 shunts requiring intervention, 1 POS recurrence
Rao 2001 10 Perc 100 19 None Median 1 year 1 residual shunt requiring intervention
Godart 2000 6 Perc 91 1 death (unrelated septic shock), 1 CVA Up to 2.5 years No late complications or repeat procedures
Waight 2000 4 Perc 100 16 None
Bakris 1997 4 Surg 100 None
Landzberg 1995 8 Perc 100 2 device embolizations, retrieved successfully Mean 2.3 years 2 deaths from cancer, 1 from nonembolic CVA

Abbreviations: CVA, cerebrovascular accident; Perc, percutaneous intervention; POS, platypnea‐orthodeoxia syndrome; SpO2, oxygen saturation; Surg, surgical intervention; TIA, transient ischemic attack.

Symptomatic improvement is seen in >95% of patients treated with percutaneous closure. There is also an average increase in upright arterial oxygen saturation of 10% to 20%. Major adverse events are rare, and are typically attributable to a severe preexisting illness (eg, septic shock), rather than the procedure itself. In the only series that consisted of both percutaneous and surgical intervention, decreased morbidity and shortened hospital stay in the percutaneous group were the only significant differences observed, although the number of patients was small.19 When weighing surgical and percutaneous closure, it should be noted that septal hypermobility does not preclude a patient from percutaneous treatment.30

Prognosis

There have been limited long‐term follow‐up results of POS patients published to date (Table 3). However, these data do suggest a good prognosis, both for shunt correction and symptom improvement. The 78‐patient series by Guerin et al in 2005 has been the largest to date.20 At a mean 15‐month follow‐up, only 1 patient required reintervention. At 6 months, a small shunt was observed on echocardiogram in only 6 patients, none of which were symptomatic. Importantly, there were no major adverse events related to the procedure.

The longest follow‐up period to date has been a mean of 2.9 years, from the 18‐patient series reported by Delgado et al in 2004.21 During follow‐up, moderate shunt recurred in 2 patients, only 1 of which was symptomatic. There were no deaths during follow‐up. At 2.9 years, the actuarial risk of recurrent POS was 4.6%, and the actuarial risk of reintervention was 9.2%. Larger series looking at PFO closure in general have reported even lower rates of shunt recurrence, suggesting that the positive results of percutaneous POS treatment should be durable.31

Summary

POS is a rare but clinically important syndrome characterized by dyspnea and arterial oxygen desaturation that is worsened by standing and relieved by recumbency. In cardiac POS, an ASD or PFO connects the right and left circulations. A second defect, such as a dilated aorta, prominent eustachian valve, or pneumonectomy then allows right‐to‐left shunting through the interatrial communication. Diagnosis is made through pulse oximetry to confirm orthodeoxia and through transesophageal echocardiography with bubble study to visualize the shunt. Although data are limited for this rare syndrome, percutaneous closure has thus far proven safe and effective.

Acknowledgments

The authors thank Dr. Peter Block for his guidance in submitting this manuscript.

The authors have no funding, financial relationships, or conflicts of interest to disclose.

References

  • 1.Elixhauser A, Owens P. Reasons for being admitted to the hospital through the emergency department, 2003. HCUP statistical brief #2. February 2006. Agency for Healthcare Research and Quality; Rockville, MD: http://www.hcup‐us.ahrq.gov/reports/statbriefs/sb2.pdf. Accessed: March 2, 2013. [PubMed] [Google Scholar]
  • 2. Sarkar S, Amelung P. Evaluation of the dypsneic patient in the office. Prim Care. 2006;33:643–657. [DOI] [PubMed] [Google Scholar]
  • 3. Cheng TO. Platypnea‐orthodeoxia syndrome: etiology, differential diagnosis, and management. Catheter Cardiovasc Interv. 1999;47:64–66. [DOI] [PubMed] [Google Scholar]
  • 4. Chen GP, Goldberg SL, Gill EA Jr. Patent foramen ovale and the platypnea‐orthodeoxia syndrome. Cardiol Clin. 2005;23:85–89. [DOI] [PubMed] [Google Scholar]
  • 5. Godart F, Rey C. Platypnea‐orthodeoxia syndrome: a probably underestimated syndrome? Chest. 2001;119:1624–1625. [DOI] [PubMed] [Google Scholar]
  • 6. Burchell HB, Wood EH. Reproducibility of values for oxygen saturation of arterial blood, and magnitude of venous‐arterial shunts in patients with congenital cardiac malformations. J Appl Physiol. 1949;1:560–566. [DOI] [PubMed] [Google Scholar]
  • 7. Cheng TO. Platypnea‐orthodeoxia and blockpnea as two unrecognized or underdiagnosed causes of medically unexplained dyspnea. Chin Med J. 2004;117:1116. [PubMed] [Google Scholar]
  • 8. Cheng TO. Mechanisms of platypnea‐orthodeoxia: what causes water to flow uphill? Circulation. 2002;105:e47. [PubMed] [Google Scholar]
  • 9. Rao PS. Transcatheter management of platypnea‐orthodeoxia syndrome. J Invasive Cardiol. 2004;16:583–584. [PubMed] [Google Scholar]
  • 10. Yeo KK, Rogers JH. Dual mechanism platypnea‐orthodeoxia syndrome from severe right coronary artery stenosis and a patent foramen ovale. Catheter Cardiovasc Interv. 2007;70:440–444. [DOI] [PubMed] [Google Scholar]
  • 11. Zanchetta M, Rigatelli G, Ho SY. A mystery featuring right‐to‐left shunting despite normal intracardiac pressure. Chest. 2005;128:998–1002. [DOI] [PubMed] [Google Scholar]
  • 12. Hsu P, Leu H, Lu T, et al. Platypnea‐orthodeoxia syndrome occurring after a blunt chest trauma with acute tricuspid regurgitation. Am J Med. 2004;117:890–891. [DOI] [PubMed] [Google Scholar]
  • 13. Nagata T, Matsumoto A, Uehara Y, et al. Oxygenation abnormalities in normoxemic patients with mild liver cirrhosis. Intern Med. 2002;41:435–440. [DOI] [PubMed] [Google Scholar]
  • 14. Soliman OI, Geleijnse ML, Meijboom FJ, et al. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr. 2007;8:S2–S12. [DOI] [PubMed] [Google Scholar]
  • 15. Afonso L, Kottam A, Niraj A, et al. Usefulness of intravenously administered fluid replenishment for detection of patent foramen ovale by transesophageal echocardiography. Am J Cardiol. 2010;106:1054–1058. [DOI] [PubMed] [Google Scholar]
  • 16. Marini C, Miniati M, Pratali L, et al. Interatrial right‐to‐left shunt after lung surgery: diagnostic value of perfusion lung scanning. Am J Med Sci. 2004;328:180–184. [DOI] [PubMed] [Google Scholar]
  • 17. Dundon B, Psaltis P, Worthley S. Cardiac magnetic resonance and “augmented” right‐to‐left intracardiac shunting through a patent foramen ovale. J Invasive Cardiol. 2008;20:197–198. [PubMed] [Google Scholar]
  • 18. Sanikommu V, Lasorda D, Poornima I. Anatomical factors triggering platypnea‐orthodeoxia in adults. Clin Cardiol. 2009;32:E55–E57. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Toffart AC, Bouvaist H, Feral V, et al. Hypoxemia‐orthodeoxia related to patent foramen ovale without pulmonary hypertension. Heart Lung. 2008;37:385–389. [DOI] [PubMed] [Google Scholar]
  • 20. Guerin P, Lambert V, Godart F, et al. Transcatheter closure of patent foramen ovale in patients with platypnea‐orthodeoxia: results of a multicentric French registry. Cardiovasc Intervent Radiol. 2005;28:164–168. [DOI] [PubMed] [Google Scholar]
  • 21. Delgado G, Inglessis I, Martin‐Herrero F, et al. Management of platypnea‐orthodeoxia syndrome by transcatheter closure of atrial communication: hemodynamic characteristics, clinical and echocardiographic outcome. J Invasive Cardiol. 2004;16:578–582. [PubMed] [Google Scholar]
  • 22. Rao P, Palacios I, Bach R, et al. Platypnea‐orthodeoxia: management by transcatheter buttoned device implantation. Catheter Cardiovasc Interv. 2001;54:77–82. [DOI] [PubMed] [Google Scholar]
  • 23. Waight D, Cao Q, Hijazi Z. Closure of patent foramen ovale in patients with orthodeoxia‐platypnea using the amplatzer devices. Catheter Cardiovasc Interv. 2000;50:195–198. [DOI] [PubMed] [Google Scholar]
  • 24. Godart F, Rey C, Prat A, et al. Atrial right‐to‐left shunting causing severe hypoxaemia despite normal right‐sided pressures. Report of 11 consecutive cases corrected by percutaneous closure. Eur Heart J. 2000;21:483–489. [DOI] [PubMed] [Google Scholar]
  • 25. Bakris N, Siddiqi A, Fraser CJ, et al. Right‐to‐left interatrial shunt after pneumonectomy. Ann Thorac Surg. 1997;63:198–201. [DOI] [PubMed] [Google Scholar]
  • 26. Landzberg M, Sloss L, Faherty C, et al. Orthodeoxia‐platypnea due to intracardiac shunting ‐ relief with transcatheter double umbrella closure. Cathet Cardiovasc Diagn. 1995;36:247–250. [DOI] [PubMed] [Google Scholar]
  • 27. Blanche C, Noble S, Roffi M, et al. Platypnea‐orthodeoxia syndrome in the elderly treated by percutaneous patent foramen ovale closure: a case series and literature review. Eur J Intern Med. 2013;24:813–817. [DOI] [PubMed] [Google Scholar]
  • 28. Zavalloni D, Lisignoli V, Barbaro C, et al. Platypnoea‐orthodeoxia syndrome secondary to patent foramen ovale (PFO): a challenging subset for PFO percutaneous closure. Heart Lung Circ. 2013;22:642–646. [DOI] [PubMed] [Google Scholar]
  • 29. Takaya Y, Akagi T, Kijima Y, et al. Transcatheter closure of right‐to‐left atrial shunt in patients with platypnea‐orthodeoxia syndrome associated with aortic elongation [published online ahead of print January 31, 2014]. Cardiovasc Interv Ther. doi: 10.1007/s12928-014-0244-x. [DOI] [PubMed] [Google Scholar]
  • 30. Scott N, King M, McQuillan B, et al. Effect of atrial septal mobility on transcatheter closure of interatrial communications. Echocardiography. 2003;20:711–714. [DOI] [PubMed] [Google Scholar]
  • 31. Onorato E, Melzi G, Casilli F, et al. Patent foramen ovale with paradoxical embolism: mid‐term results of transcatheter closure in 256 patients. J Intervent Cardiol. 2003;16:43–50. [DOI] [PubMed] [Google Scholar]

Articles from Clinical Cardiology are provided here courtesy of Wiley

RESOURCES